In this episode, Simon Szewach, the executive chairman and co-founder of Gelteq, discusses the innovative gel-based medications and nutraceuticals developed by his company. He shares insights into the journey of Gelteq from its inception in Australia to becoming a public company in the US, highlighting the unique advantages of gel technology in delivering medications, especially for those with swallowing difficulties. Simon also elaborates on the company's focus on both human and pet health, the regulatory landscape, and the future growth prospects of Gelteq in the pharmaceutical industry.

Ver todos los episodios